Relationship between p53 mutation incidence in oral cavity squamous cell carcinomas and patient tobacco use

被引:47
作者
Lazarus, P
Stern, J
Zwiebel, N
Fair, A
Richie, JP
Schantz, S
机构
[1] AMER HLTH FDN,DIV PATHOL & TOXICOL,VALHALLA,NY 10595
[2] AMER HLTH FDN,DIV NUTR CARCINOGENESIS,VALHALLA,NY 10595
[3] NEW YORK EYE & EAR INFIRM,DEPT OTOLARYNGOL,NEW YORK,NY 10003
[4] MEM SLOAN KETTERING CANC CTR,HEAD & NECK SERV,NEW YORK,NY 10021
关键词
D O I
10.1093/carcin/17.4.733
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
It is well-established that a high incidence of p53 mutations exist in oral cavity squamous cell carcinomas (OCSCCs), To determine whether p53 mutations are etiologically associated with OCSCC development or are associated with exposure to specific carcinogens, we have analyzed the conserved regions of the p53 gene (exons 5-9) in 48 OCSCCs obtained from patients with varied tobacco and alcohol use histories by polymerase chain reaction/single strand conformational polymorphism (PCR/SSCP) and DNA sequencing analysis, Thirty-eight percent (18/48) of the OCSCCs exhibited a mutation in exons 5-9 of the p53 gene, There was a significantly higher incidence of p53 mutations in OCSCCs from tobacco users (predominantly cigarette smokers) compared to those who had never used tobacco, No increase in the incidence of p53 mutation was observed in tobacco users who drank alcohol. G to A transitions and deletions were the predominant mutations observed in OCSCCs from tobacco users. No specific pattern of mutation was observed in OCSCCs from those subjects who had never used tobacco, These data suggest that a history of tobacco use was associated with a high incidence of p53 mutations in patients with OCSCC and that tobacco carcinogens induce a specific pattern of mutations in oral cavity tissue in vivo.
引用
收藏
页码:733 / 739
页数:7
相关论文
共 30 条
  • [1] SEQUENCING OF DOUBLE-STRANDED POLYMERASE CHAIN-REACTION PRODUCTS FOR MUTATION ANALYSIS
    ANDERSON, RD
    BAO, CY
    MINNICK, DT
    BAXTER, J
    VEIGL, ML
    SEDWICK, WD
    [J]. MUTATION RESEARCH, 1993, 288 (01): : 181 - 185
  • [2] Ausubel F.M., 1988, CURRENT PROTOCOLS MO, V1
  • [3] PATTERNS OF EXPRESSION OF THE P53 TUMOR SUPPRESSOR IN HUMAN BREAST TISSUES AND TUMORS INSITU AND INVITRO
    BARTEK, J
    BARTKOVA, J
    VOJTESEK, B
    STASKOVA, Z
    REJTHAR, A
    KOVARIK, J
    LANE, DP
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1990, 46 (05) : 839 - 844
  • [4] ROLE OF CLARA CELLS AND TYPE-II CELLS IN THE DEVELOPMENT OF PULMONARY TUMORS IN RATS AND MICE FOLLOWING EXPOSURE TO A TOBACCO-SPECIFIC NITROSAMINE
    BELINSKY, SA
    DEVEREUX, TR
    WHITE, CM
    FOLEY, JF
    MARONPOT, RR
    ANDERSON, MW
    [J]. EXPERIMENTAL LUNG RESEARCH, 1991, 17 (02) : 263 - 278
  • [5] A ROLE FOR SUNLIGHT IN SKIN-CANCER - UV-INDUCED P53 MUTATIONS IN SQUAMOUS-CELL CARCINOMA
    BRASH, DE
    RUDOLPH, JA
    SIMON, JA
    LIN, A
    MCKENNA, GJ
    BADEN, HP
    HALPERIN, AJ
    PONTEN, J
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (22) : 10124 - 10128
  • [6] ASSOCIATION BETWEEN CIGARETTE-SMOKING AND MUTATION OF THE P53 GENE IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    BRENNAN, JA
    BOYLE, JO
    KOCH, WM
    GOODMAN, SN
    HRUBAN, RH
    EBY, YJ
    COUCH, MJ
    FORASTIERE, AA
    SIDRANSKY, D
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (11) : 712 - 717
  • [7] SELECTIVE G-MUTATION TO T-MUTATION OF P53 GENE IN HEPATOCELLULAR-CARCINOMA FROM SOUTHERN AFRICA
    BRESSAC, B
    KEW, M
    WANDS, J
    OZTURK, M
    [J]. NATURE, 1991, 350 (6317) : 429 - 431
  • [8] DAVIS S, 1987, LANCET, V2, P910
  • [9] DEQUE P, 1986, NEW ENGL J MED, V315, P647
  • [10] ELEVATED P53 EXPRESSION CORRELATES WITH A HISTORY OF HEAVY SMOKING IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    FIELD, JK
    SPANDIDOS, DA
    MALLIRI, A
    GOSNEY, JR
    YIAGNISIS, M
    STELL, PM
    [J]. BRITISH JOURNAL OF CANCER, 1991, 64 (03) : 573 - 577